BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 24432613)

  • 1. [The clinical and epidemic characteristics of shingles (herpes zoster) and its prevention with vaccines].
    Afonina NM; Mikheeva IV
    Ter Arkh; 2013; 85(11):130-3. PubMed ID: 24432613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoster vaccine: current status and future prospects.
    Oxman MN
    Clin Infect Dis; 2010 Jul; 51(2):197-213. PubMed ID: 20550454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoster vaccine live.
    Kockler DR; McCarthy MW
    Pharmacotherapy; 2007 Jul; 27(7):1013-9. PubMed ID: 17594207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoster vaccine live for the prevention of shingles in the elderly patient.
    Zussman J; Young L
    Clin Interv Aging; 2008; 3(2):241-50. PubMed ID: 18686747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Disseminated Varicella Zoster in Immunosuppressed Patients Receiving Zoster Vaccination.
    Bubb MR
    Mayo Clin Proc; 2015 Nov; 90(11):1585-6. PubMed ID: 26541254
    [No Abstract]   [Full Text] [Related]  

  • 7. Varicella-zoster virus vaccination under the exogenous boosting hypothesis: two ethical perspectives.
    Luyten J; Ogunjimi B; Beutels P
    Vaccine; 2014 Dec; 32(52):7175-8. PubMed ID: 25454883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In reply--Risk of Disseminated Varicella Zoster in Immunosuppressed Patients Receiving Zoster Vaccination.
    Cheetham TC; Sy LS; Jacobsen SJ
    Mayo Clin Proc; 2015 Nov; 90(11):1586-7. PubMed ID: 26541255
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of Herpes Zoster and Disseminated Varicella Zoster in Patients Taking Immunosuppressant Drugs at the Time of Zoster Vaccination.
    Cheetham TC; Marcy SM; Tseng HF; Sy LS; Liu IL; Bixler F; Baxter R; Donahue JG; Naleway AL; Jacobsen SJ
    Mayo Clin Proc; 2015 Jul; 90(7):865-73. PubMed ID: 26051268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of herpes zoster and its painful and debilitating complications.
    Johnson R; McElhaney J; Pedalino B; Levin M
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S43-8. PubMed ID: 18162246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases.
    Khan N; Trivedi C; Kavani H; Medvedeva E; Lewis J; Yang YX
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1341-1347. PubMed ID: 30326303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and clinical characteristics of herpes zoster after lung transplantation.
    Manuel O; Kumar D; Singer LG; Cobos I; Humar A
    J Heart Lung Transplant; 2008 Jan; 27(1):11-6. PubMed ID: 18187081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Shingles vaccine: which recommendations in 2014?].
    Vionnet J; Hart K; Spertini F
    Rev Med Suisse; 2014 Apr; 10(426):869-72, 874-5. PubMed ID: 24834646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine.
    Litt J; Booy R; Bourke D; Dwyer DE; Leeb A; McCloud P; Stein AN; Woodward M; Cunningham AL
    Hum Vaccin Immunother; 2020 Dec; 16(12):3081-3089. PubMed ID: 32420793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoster vaccine in older adults.
    Fried R
    J Am Geriatr Soc; 2010 Sep; 58(9):1799-800. PubMed ID: 20863342
    [No Abstract]   [Full Text] [Related]  

  • 17. Zoster vaccine protects against shingles.
    BMJ; 2013 Apr; 346():f2389. PubMed ID: 23596220
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of shingles by varicella zoster virus vaccination.
    Holodniy M
    Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.